ArticleJournal of diabetes and metabolic disorders2017

SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study.

Héctor Eloy Tamez-Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.